🇺🇸 FDA
Patent

US 6982168

Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6982168 (Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P35/00